Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network

Buchbinder, Rachelle (Primary Chief Investigator (PCI))
Maher, Chris (Chief Investigator (CI))
March, Lynette M. (Chief Investigator (CI))
Day, Richard O. (Chief Investigator (CI))
Hinman, Rana S. (Chief Investigator (CI))
Harris, Ian A. (Chief Investigator (CI))
Ferreira, Manuela (Chief Investigator (CI))
Glaziou, Paul (Chief Investigator (CI))
Green, Sally (Chief Investigator (CI))
Billot, Laurent (Chief Investigator (CI))
Latimer, Jane (Associate Investigator (AI))
Whittle, Samuel Lawrence (Associate Investigator (AI))
Cicuttini, Flavia (Associate Investigator (AI))
Hill, Catherine Louise (Associate Investigator (AI))
Lin, Christine (Associate Investigator (AI))
Taylor, William John (Associate Investigator (AI))
Hunter, David (Associate Investigator (AI))
Harris, Anthony (Associate Investigator (AI))
Winzenberg, Tania Maree (Associate Investigator (AI))
McAuley, James (Associate Investigator (AI))

Project: Research

Project Description

NHMRC Centre of Research Excellence

Short title	ANZMUSC Clinical Trial Network
Acronym	ANZMUSC
Status	Finished
Effective start/end date	1/01/18 → 31/12/22

4 Article
1 Review Article

Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT)
Taylor, W. J., Willink, R., O Connor, D. A., Patel, V., Bourne, A., Harris, I. A., Whittle, S. L., Richards, B., Clavisi, O., Green, S., Hinman, R. S., Maher, C. G., Cahill, A., McPherson, A., Hewson, C., May, S. E., Walker, B., Robinson, P. C., Ghersi, D., Fitzpatrick, J., & 5 othersWinzenberg, T., Fallon, K., Glasziou, P., Billot, L. & Buchbinder, R., Mar 2023, In: PLoS ONE. 18, 3, 17 p., e0281308.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

1 Citation (Scopus)
Australian recommendations on tapering of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in inflammatory arthritis
Whittle, S. L., Glennon, V., Johnston, R. V., Avery, J. C., Bell, J. S., Brennan, S. E., Fong, C., Hissaria, P., Horgan, B., O'Neill, S., Pisaniello, H. L., Trevena, L., Whittaker, G. A., Wluka, A. & Buchbinder, R., Oct 2022, In: Internal Medicine Journal. 52, 10, p. 1799-1805 7 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

2 Citations (Scopus)
Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework
Cross, A. J., Buchbinder, R., Mathieson, S., Bourne, A., Maher, C. G., Lin, C. W. C. & O'Connor, D. A., May 2022, In: BMJ Quality and Safety. 31, 5, p. 387-400 14 p.
Research output: Contribution to journal › Article › Research › peer-review

6 Citations (Scopus)

Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network

Project Details

Project Description

Research output

Which clinical research questions are the most important? Development and preliminary validation of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network Research Question Importance Tool (ANZMUSC-RQIT)

Australian recommendations on tapering of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in inflammatory arthritis

Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework